deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT03180177

Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer (EHNPCTASEOC)

A Phase III Multicenter Prospective Randomized Controlled Clinical Trial of HIPEC as NACT and Postoperative Chemotherapy After Interval Debulking Surgery in the Treatment of Advanced-Stage Epithelial Ovarian Cancer

Sponsor: Beijing Obstetrics and Gynecology Hospital

Updated 15 times since 2017 Last updated: Jan 22, 2018 Started: Mar 1, 2018 Primary completion: Jul 1, 2021 Completion: Jul 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Epithelial Ovarian Cancer and Fallopian Tube Cancer and is currently ongoing. Beijing Obstetrics and Gynecology Hospital leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jun 2017 – ~Oct 2017 · 4 months · monthly snapshot~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Apr 2020 · 20 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

15 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE3

  2. Aug 2025 — Sep 2025 [monthly]

    Unknown PHASE3

  3. Sep 2024 — Aug 2025 [monthly]

    Unknown PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  5. Nov 2022 — Jul 2024 [monthly]

    Unknown Status PHASE3

Show 10 earlier versions
  1. Sep 2022 — Nov 2022 [monthly]

    Unknown Status PHASE3

    Status: Not Yet RecruitingUnknown Status

  2. Jan 2021 — Sep 2022 [monthly]

    Not Yet Recruiting PHASE3

  3. Apr 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

  4. Aug 2018 — Apr 2020 [monthly]

    Not Yet Recruiting PHASE3

  5. Jul 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE3

  6. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE3

  7. Dec 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

  8. Nov 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE3

  9. Oct 2017 — Nov 2017 [monthly]

    Not Yet Recruiting PHASE3

  10. Jun 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing Obstetrics and Gynecology Hospital
  • Cancer Hospital of Guizhou Province
  • Chinese PLA General Hospital
  • Chongqing Cancer Institute
  • First Affiliated Hospital, Sun Yat-Sen University
  • Fourth Affiliated Hospital of Guangxi Medical University
  • Hebei Medical University Fourth Hospital
  • Henan Cancer Hospital
  • Henan Provincial People's Hospital
  • Obstetrics & Gynecology Hospital of Fudan University
  • Peking Union Medical College Hospital
  • Peking University Cancer Hospital & Institute
  • Peking University People's Hospital
  • RenJi Hospital
  • Shandong Cancer Hospital and Institute
  • Shu-Zhong Cui
  • Southern Medical University, China
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
  • The Second Hospital of Hebei Medical University
  • The Third Affiliated Hospital of Guangzhou Medical University
  • The Third Xiangya Hospital of Central South University
  • Third Affiliated Hospital, Sun Yat-Sen University
  • Tianjin Medical University Cancer Institute and Hospital
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • West China Second University Hospital
  • Wuhan University
  • Xiangya Hospital of Central South University
  • Xinqiao Hospital of Chongqing
Data source: Affiliated Cancer Hospital & Institute of Guangzhou Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations